RGDXQ — Response Genetics Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
Annual cashflow statement for Response Genetics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2010 December 31st | C2011 December 31st | 2012 December 31st | 2013 December 31st | 2014 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -4.67 | -5.7 | -7.76 | -8.02 | -13.7 |
| Depreciation | |||||
| Non-Cash Items | 1.28 | 2.19 | 2.17 | 3.64 | 6.76 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -3.57 | -1.94 | -2.89 | -2.74 | -8.19 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -6.49 | -5.08 | -8.01 | -6.49 | -14.3 |
| Capital Expenditures | -0.392 | -0.391 | -0.957 | -0.808 | -0.104 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 0 | — | — | — | 0.002 |
| Sale of Fixed Assets | |||||
| Cash from Investing Activities | -0.392 | -0.391 | -0.957 | -0.808 | -0.102 |
| Financing Cash Flow Items | 0 | — | — | — | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 3.95 | 3.13 | 16.3 | 6.41 | 8.47 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -2.94 | -2.42 | 7.34 | -0.893 | -5.93 |